This issue features highlights from the 16th ACTO Annual Congress in Singapore, academic insights into cartilage cell sheet engineering, and updates on cellular and gene therapy (CGT) advances and industrial developments. Through expert perspectives, regulatory discussions, and translational research updates, this edition reflects ACTO’s continued commitment to advancing regenerative medicine and fostering global collaboration.
